The US Food and Drug Administration (FDA) has proposed simplifying the timing of vaccination against COVID-19 and that the doses are annual, as is the case with the common flu.
In a series of documents published this Monday on its website, the US regulator indicated that it is possible that most of the population only needs an annual dose to protect themselves from the disease, regardless of what they have previously received.
The FDA notes that young people who have not been exposed to COVID, the elderly, or those who are immunosuppressed may need two doses per year.
The idea of this body would be to evaluate the possible new variants of the virus that are circulating during the year and choose one that it believes will be prevalent the following fall to develop the vaccine, as is usually done with the flu.
In its documents, the agency advocates creating a single composition for the vaccine, instead of what it has been until now, with a combination of monovalent sera (those used in the original COVID vaccines and in the first booster) and other polyvalent ones (those of the reinforcement against omicron).
“Simplification of vaccine composition should reduce complexity, decrease errors in vaccine administration due to the complexity of different vial presentations, and potentially increase vaccination compliance by allowing clearer communication.”, details the FDA in his writings.
The Advisory Committee on Vaccines and Biologicals of the FDAan independent body made up of scientists, will evaluate the future of the COVID vaccine in the United States this Thursday and vote on whether or not to support the regulator’s recommendations.
EFE source
Source: Gestion
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
